Shirley Ryan AbilityLab is looking for adults with sub-acute spinal cord injuries (SCI) to participate in a trial of experimental drug NVG-291. For 12 weeks, participants will receive daily subcutaneous injections of either NVG-291 or a placebo. “In lab studies, NVG-291 improved locomotion and bladder recovery,” an AbilityLab announcement said. “Final testing of central nervous…
AbilityLab Seeks Cervical SCI Participants for Drug Study
Neuralink Now Enrolling Participants for Brain-Computer Interface Clinical Trial
The company is seeking people with quadriplegia or ALS.
Neuralink, an American neurotechnology developer, is now enrolling participants for a human clinical trial of its Precise Robotically Implanted Brain Computer Interface (PRIME). In a September news announcement, the company said its R1 surgical robot would place Neuralink’s N1 implant into trial participants with the goal of “enabling people with paralysis to control external devices…